Seelos Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1996
Market Capitalization	1	7	73	167	84	36	Upgrade
Market Cap Growth	-89.18%	-89.72%	-56.40%	97.72%	133.74%	567.75%	Upgrade
Enterprise Value	14	19	77	107	78	26	Upgrade
PE Ratio	-	-0.20	-0.99	-2.53	-4.42	-0.70	Upgrade
PS Ratio	0.79	3.39	-	-	-	96.30	Upgrade
PB Ratio	-0.24	-0.22	-6.86	2.91	32.82	-5158.98	Upgrade
P/FCF Ratio	-0.44	-0.31	-1.18	-3.41	-4.04	-1.87	Upgrade
P/OCF Ratio	-0.44	-0.31	-1.18	-3.41	-4.04	-1.87	Upgrade
EV/Sales Ratio	7.18	8.49	-	-	-	68.94	Upgrade
EV/EBITDA Ratio	-0.77	-0.50	-1.05	-1.66	-4.14	-0.50	Upgrade
EV/EBIT Ratio	-0.77	-0.49	-1.05	-1.66	-4.14	-0.50	Upgrade
EV/FCF Ratio	-1.14	-0.78	-1.26	-2.19	-3.75	-1.34	Upgrade
Debt / Equity Ratio	-0.40	-0.42	-1.90	0.33	3.78	-	Upgrade
Debt / EBITDA Ratio	-0.49	-0.38	-0.27	-0.29	-0.51	-	Upgrade
Debt / FCF Ratio	-0.72	-0.60	-0.33	-0.39	-0.46	-	Upgrade
Quick Ratio	0.04	0.10	0.62	9.50	2.11	0.95	Upgrade
Current Ratio	0.10	0.14	0.90	10.07	2.36	1.03	Upgrade
Asset Turnover	0.29	0.19	0	0	0	0.03	Upgrade
Interest Coverage	-296.97	-504.09	-5251.43	-40.33	-115.47	-1766.41	Upgrade
Return on Equity (ROE)	75.20%	115.00%	-425.50%	-111.10%	-387.10%	-1119.30%	Upgrade
Return on Assets (ROA)	-399.70%	-321.30%	-157.60%	-89.20%	-155.00%	-410.60%	Upgrade
Return on Capital (ROIC)	188.42%	210.04%	-745.62%	-80.84%	-152.56%	424957.14%	Upgrade
Earnings Yield	-1736.86%	-506.63%	-101.05%	-39.57%	-22.63%	-141.93%	Upgrade
FCF Yield	-1166.19%	-319.80%	-84.66%	-29.36%	-24.78%	-53.46%	Upgrade
Buyback Yield / Dilution	-246.73%	-38.20%	-17.03%	-103.03%	-120.43%	-559.03%	Upgrade
Total Shareholder Return	-246.73%	-38.20%	-17.03%	-103.03%	-120.43%	-559.03%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).